Sep 17, 2013 01:03 PM EDT
Agenus Brain Cancer Vaccine Increases Survival Rates
Agenus Inc., a biotechnology company, released information regarding a recent analysis from a second trial of a experimental brain cancer vaccine, stating that the drug has increased the survival of patients without their cancer worsening during mid-stage periods when compared with other treatments....